Baniak Lynn M, Luyster Faith S, Raible Claire A, McCray Ellesha E, Strollo Patrick J
Veteran Affairs Pittsburgh Healthcare System, Pittsburgh, PA 15240, USA.
Department of Health and Community Systems, School of Nursing, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Vaccines (Basel). 2021 Aug 4;9(8):858. doi: 10.3390/vaccines9080858.
Even with the availability of COVID-19 vaccines, factors associated with vaccine hesitancy and uptake among nurses are unknown. This study evaluated COVID-19 vaccine hesitancy and uptake of nursing staff during one of the first COVID-19 vaccine rollouts in the United States. A cross-sectional survey was conducted during February 2021 among nursing staff working in a large medical center in central United States. There were 276 respondents; 81.9% of participants were willing to receive the vaccine during the initial rollout, 11.2% were hesitant, and only 5.1% were unwilling. The hesitant group was likely to report having inadequate information to make an informed decision about whether to receive the vaccine (45.2%) and about vaccine expectations (32.3%). The majority (83.3%) received at least one dose of the vaccine. Having greater than 10 years' work experience (OR 3.0, 95% CI 1.16-7.9) and confidence in vaccine safety (OR 7.78, 95% CI 4.49-13.5) were significantly associated with vaccine uptake. While our study indicates higher vaccine uptake among nursing staff during an active vaccine rollout, there remains sustained hesitancy and unwillingness to uptake. For those hesitant to receive the COVID-19 vaccine, public health efforts to provide more data on side effects and efficacy may help increase vaccine uptake.
即使有了新冠疫苗,护士群体中与疫苗犹豫和接种相关的因素仍不明确。本研究评估了美国首次新冠疫苗接种期间护士群体对新冠疫苗的犹豫态度和接种情况。2021年2月,对美国中部一家大型医疗中心的护理人员进行了横断面调查。共有276名受访者;81.9%的参与者在首次接种期间愿意接种疫苗,11.2%的人犹豫不决,只有5.1%的人不愿意接种。犹豫不决的群体中,很可能有45.2%的人表示没有足够信息来就是否接种疫苗做出明智决定,32.3%的人表示没有足够信息了解疫苗预期。大多数人(83.3%)接种了至少一剂疫苗。工作经验超过10年(比值比3.0,95%置信区间1.16 - 7.9)以及对疫苗安全性有信心(比值比7.78,95%置信区间4.49 - 13.5)与疫苗接种显著相关。虽然我们的研究表明在积极的疫苗接种期间护理人员的疫苗接种率较高,但仍有持续的犹豫和不愿接种的情况。对于那些犹豫是否接种新冠疫苗的人,提供更多关于副作用和疗效数据的公共卫生措施可能有助于提高疫苗接种率。